Smartphone support for stimulant use disorder

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, remote study assigns adults with stimulant use disorder to one of two smartphone-based behavioral service packages with a 50/50 chance of each. Participants must be 18 or older, speak and read English, own a smartphone, and agree to let the team contact their healthcare providers and review insurance use; pregnant people and those requiring acute inpatient detox are excluded. The intervention is a digital therapeutic smartphone system delivered entirely remotely by DynamiCare Health, with no medication provided. Investigators will monitor app usage and link to healthcare visit and claims data over time to see whether app users have reduced clinic, emergency department, or hospital visits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults who are at least 18 years old, speak/read English, have a smartphone, and who meet criteria for Stimulant Use Disorder, active or early remission. If being discharged to outpatient or intensive outpatient care, the patient is eligible.

Exclusion Criteria:

* Unwilling to authorize communication with any treatment provider(s), requiring acute detoxification from alcohol or opioids or residential or hospital treatment, or other obstacle to longitudinal participation in the study.
* Currently pregnant

Where it's running

• This is an At-Home Study - no travel or on-site visits are needed at all; Main Office: 6 Liberty Sq, #2102
  Boston, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Carla J Rash, PhD — UConn Health
• Study coordinator: David R Gastfriend, MD
• Email: enrollment@dynamicarehealth.com
• Phone: 860-679-4689

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DynamiCare-based program to support re-entry for stimulant users at risk for HIV

  This study tests whether adding the DynamiCare mobile app plus patient navigation helps people released from justice settings who use stimulants to start HIV care (ART/PrEP) and reduce stimulant use.

  Recruiting at 2 sites University of Texas Southwestern Medical Center · New Haven, Connecticut and 1 other locations · NCT07136363

• Repetitive Transcranial Magnetic Stimulation for Stimulant Use Disorder in Veterans

  A randomized, placebo-controlled test to see if rTMS helps veterans with stimulant use disorder see reduced use and improved outcomes.

  Recruiting VA Office of Research and Development · Palo Alto, California · NCT07112105

• Optimizing brain stimulation techniques for stimulant use disorder

  This study is testing different brain stimulation techniques to see if they can help adults with stimulant use disorder who have recently stopped using drugs.

  Recruiting Phase 1 University of Minnesota · Minneapolis, Minnesota · NCT06790576

• Integrated care for hospitalized patients with opioid and stimulant use disorders and infections

  This study tests if a new combined care approach for patients with infections from using opioids or stimulants can help them stay healthier and avoid going back to the hospital compared to regular treatment.

  Recruiting at 4 sites University of Maryland, Baltimore · Washington D.C., District of Columbia and 3 other locations · NCT06513156

• Effects of a sleep medication on cravings and stress in stimulant use disorder

  This study is testing whether a sleep medication can help people in early recovery from stimulant use feel less stressed and have fewer cravings while they are in a treatment program.

  Recruiting Phase 2 The University of Texas Health Science Center, Houston · Houston, Texas · NCT06444256

• Using Mirtazapine to treat methamphetamine use in patients with opioid use disorder

  This study is testing if the medication Mirtazapine can help people with opioid use disorder reduce their methamphetamine use while they receive standard treatment.

  Recruiting Phase 2 Washington State University · Spokane, Washington · NCT06323837

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.